Dynavax to Report Third Quarter 2019 Financial Results and Host Conference Call on November 6
October 24 2019 - 3:05PM
Dynavax Technologies Corporation (NASDAQ: DVAX), a
biopharmaceutical company focused on commercializing novel
vaccines, will report third quarter 2019 financial results on
Wednesday, November 6, 2019, after the U.S. financial markets
close.
Dynavax will host a conference call and live
audio webcast on Wednesday, November 6, 2019 at 4:30 p.m. (ET)/1:30
p.m. (PT).
The live audio webcast may be accessed through
the “Events & Presentations” page on the “Investors” section of
the company’s website at www.dynavax.com. Alternatively,
participants may dial 800-479-1004 (domestic) or 720-543-0206
(international) and refer to conference ID 5687867.
The archived conference call will be available
on Dynavax’s website beginning approximately two hours after the
event and will be archived and available for replay for at least 30
days after the event.
About DynavaxDynavax discovers,
develops and commercializes novel vaccines. The Company launched
its first commercial product, HEPLISAV-B® [Hepatitis B Vaccine
(Recombinant), Adjuvanted], in February 2018, following U.S. FDA
approval for prevention of infection caused by all known subtypes
of hepatitis B virus in adults age 18 years and older. For
more information, visit www.dynavax.com and follow the company on
LinkedIn.
Contact:Derek Cole Investor
Relations Advisory Solutions IR@dynavax.com
Dynavax Technologies (NASDAQ:DVAX)
Historical Stock Chart
From Apr 2024 to May 2024
Dynavax Technologies (NASDAQ:DVAX)
Historical Stock Chart
From May 2023 to May 2024